Literature DB >> 23078910

EBV-associated lymphoproliferative disorders misdiagnosed as Crohn's disease.

Hee Kyong Na1, Byong Duk Ye, Suk-Kyun Yang, Dong-Hoon Yang, Kee Wook Jung, Kyung Jo Kim, Jeong-Sik Byeon, Seung-Jae Myung, Jooryung Huh, Jin-Ho Kim.   

Abstract

Epstein-Barr virus (EBV) plays an etiological role in various diseases. EBV-associated lymphoproliferative disorder (LPD) is usually observed in individuals with congenital or acquired immune deficiencies but was also recently reported in non-immunocompromised individuals. Two cases of immunocompetent patients with EBV-associated T-cell LPD of the small bowel and colon who were initially misdiagnosed as Crohn's disease (CD) are reported here. EBV-associated T-cell LPD with primary gastrointestinal tract involvement can manifest as multiple discrete ulcers of the small and/or large bowel that are similar to the lesions found in CD or intestinal tuberculosis. However, when patients have multiple intestinal ulcers that are not typical of CD or intestinal tuberculosis and the clinical course is unusual, clinicians should consider the possibility of EBV-associated LPD that involves the gastrointestinal tract because the treatment strategy and prognosis are completely different.
Copyright © 2012 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Crohn's disease; Epstein–Barr virus;; Lymphoproliferative disorders;

Mesh:

Substances:

Year:  2012        PMID: 23078910     DOI: 10.1016/j.crohns.2012.09.018

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  9 in total

Review 1.  EBV-associated lymphoproliferative disorder involving the gastrointestinal tract which mimic IBD in immunocompetent patients: case reports and literature review.

Authors:  Yanhua Zhou; Yanlin Zhang; Haiying Zhao; Xuan Cui; Yongqiu Wei; Yongdong Wu; Shutian Zhang; Ye Zong
Journal:  Int J Colorectal Dis       Date:  2019-10-23       Impact factor: 2.571

2.  Epstein-Barr virus-associated lymphoproliferative disorder in colon with the development of hemophagocytic syndrome of an immunocompetent patient.

Authors:  Hai-Zhou Wang; Chang Gao; Rui Zhou; Xian-Yan Shi; Ming-Xia Yu; Jun Lin; Qiu Zhao; Jing Liu
Journal:  Turk J Gastroenterol       Date:  2019-11       Impact factor: 1.852

3.  Necrotizing pancreatitis after removal of prophylactically placed pancreatic stent.

Authors:  Sridhar Sundaram
Journal:  Turk J Gastroenterol       Date:  2019-11       Impact factor: 1.852

4.  Necrotizing pancreatitis after removal of prophylactically placed pancreatic stent.

Authors:  Sridhar Sundaram
Journal:  Turk J Gastroenterol       Date:  2019-10       Impact factor: 1.852

5.  Clinical Features of Intestinal Ulcers Complicated by Epstein-Barr Virus Infection: Importance of Active Infection.

Authors:  Yuyuan Liu; Yuqin Li; Yajun Li; Shuang Wu; Xinyue Tian; Tongyu Tang; Haibo Sun; Chuan He
Journal:  Dis Markers       Date:  2021-05-03       Impact factor: 3.434

6.  A Case Report of NK-Cell Lymphoproliferative Disease With a Wide Involvement of Digestive Tract Develop Into Epstein-Barr Virus Associated NK/T Cell Lymphoma in an Immunocompetent Patient.

Authors:  Haotian Chen; Yu Zhang; Zhinong Jiang; Wei Zhou; Qian Cao
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

7.  Epstein-Barr Virus-Associated T-Cell Lymphoproliferative Disorder Presenting as Chronic Diarrhea and Intestinal Bleeding: A Case Report.

Authors:  Yaxin Wang; Yajun Li; Xiangwei Meng; Xiumei Duan; Meilan Wang; Wenqing Chen; Tongyu Tang; Yuqin Li
Journal:  Front Immunol       Date:  2018-11-16       Impact factor: 7.561

8.  Intestinal ulcers as an initial finding in EBV-associated lymphoproliferative disorder: A case report.

Authors:  Sizhu Wang; Yinghuan Dai; Jie Zhang; Dalian Ou; Chunhui Ouyang; Fanggen Lu
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

Review 9.  A new therapy in Epstein-Barr virus-associated lymphoproliferative disease: a case report and a revision of the literature.

Authors:  Lingling Xu; Hongjun Ba; Hongrong Lin; Liangying Zhong; Suping Li; Wen Tang; Zhiyong Ke; Ziyin Ye
Journal:  Ital J Pediatr       Date:  2019-11-04       Impact factor: 2.638

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.